Heyoka955/rteee huggingface dataset:
08 sep 25   buccaneer energy plc - replacement – share issuance buccaneer energy plc | buce | 0.0 0 0.0% | mkt cap: 1.99m    rns number : 3784y buccaneer energy plc 08 september 2025       the following amendments have been made to the 'share issuance' announcement released on 5 september 2025 at 5.45pm under rns no 2924y.     the changes that have been made are: shares issued are 175,000,000, replacing 142,499,999 total shares in issue are 11,524,346,616, replacing 11,491,846,616    all other details remain unchanged. the full amended text is shown below.   buccaneer energy plc ("buccaneer" or the "company")   8 september 2025   replacement - share issuance   buccaneer energy (aim:buce), the international oil & gas exploration and production company with development and production assets in texas, usa, announces that it will issue 175,000,000 shares to roast pr ltd and visitz ltd at a share price of £0.00018 as consideration for media-related services.   application for admission and total voting rights an application will be made to the london stock exchange for the additional 175,000,000 new ordinary shares to be admitted to trading on aim ("admission"); it is expected that admission will become effective on or around 12 september 2025. in accordance with the fca's disclosure guidance and transparency rules, the company confirms that on issue of the additional fundraise shares and following admission, the company's enlarged issued ordinary share capital will comprise 11,524,346,616 ordinary shares. the company does not hold any ordinary shares in treasury.  therefore, following admission, the above figure may be used by shareholders in the company as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in the company, under the fca's disclosure guidance and transparency rules.     for further information, contact:   buccaneer energy plc paul welch, ceo email: investor_relations@buccaneerenergy.co.uk    sp angel corporate finance llp (nomad/joint broker) stuart gledhill / richard hail / adam cowl   tel: +44 (0) 20 3470 0470 oak securities (joint broker) robert bell / nick price tel: +44 (0) 20 3973 3678       celicourt communications (pr/ir) mark antelme / jimmy lea tel: email: +44 (0) 20 7770 6424 buceng@celicourt.uk               this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   ioeupuawbupagbm return to news summary

Label: Gestiegen
09 sep 25   oryx int. growth fnd - investor presentation oryx international growth fund ltd gbp accum.shs | oig | 0 0 0.0% | mkt cap: 153.3m    rns number : 4820y oryx international growth fund ld 09 september 2025   9th september 2025   oryx international growth fund limited ("oryx" or the "company") investor presentation   oryx international growth fund limited is pleased to announce that portfolio managers christopher mills and nicholas mills will hold a presentation at 10.30am on thursday 9th october 2025. the presentation will contain an introduction to oryx and a review of the portfolio, followed by a q&a session. the presentation will be hosted through the digital platform investor meet company and is open to all investors. questions can be submitted pre-event via your investor meet company dashboard up until 9.00am on wednesday 8 october, or at any time during the live presentation. a recording of the presentation will be made available shortly after the event on the investor meet company platform for those not able to attend in real time. investor presentation: 10.30am, thursday 9th october 2025 if you are interested in attending the investor presentation, please register via investor meet company: https://www.investormeetcompany.com/oryx-international-growth-fund-ltd/register-investor   enquiries: bnp paribas s.a., guernsey branch tel: 01481 750850   this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   mscuwsnrvrukrar return to news summary

Label: Neutral
09 sep 25   braveheart inv group - block admission six monthly return braveheart investment group plc | brh | 2.1 0 0.0% | mkt cap: 1.65m    rns number : 4960y braveheart investment group plc 09 september 2025   9 september 2025   braveheart investment group plc (the "company")   block admission six monthly return   braveheart investment group plc (aim: brh) announces the following information in connection with its block admission pursuant to aim rule 29 and schedule six of the aim rules for companies.     name of company:   braveheart investment group plc name of scheme:   share options to directors, employees and consultants announced on 17 december 2020   period of return:   10 march 2025 to 9 september 2025 number and class of securities not issued under the scheme at the beginning of the period: 1,096,000 ordinary shares of 2 pence each in the company (the "ordinary shares")   number of securities issued under the scheme during the period:   nil   balance under the scheme of securities not yet issued at the end of the period:   1,096,000 ordinary shares number and class of securities originally admitted and the date of admission:   1,150,000 ordinary shares on 9 march 2021 contact name and telephone number:   trevor brown, chief executive officer   01738 587555     for further information:    braveheart investment group plc tel: 01738 587555 trevor brown, chief executive officer viv hallam, executive director    allenby capital limited (nominated adviser and joint broker) tel: 020 3328 5656 james reeve / ashur joseph    peterhouse capital limited (joint broker) tel: 020 7469 0936   this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   blrfffliafitiie return to news summary

Label: Neutral
09 sep 25   pensana plc - appointment of chief operating officer pensana plc | pre | 125 0 0.0% | mkt cap: 374.7m    9 september 2025   this announcement contains inside information   pensana plc ("pensana" or the "company")   appointment of chief operating officer pensana plc is pleased to announce the appointment of rare earths veteran karen brown as chief operating officer (coo), effective 1 october 2025. karen succeeds rocky smith, who will continue to consult with the company as part of the owner's team currently developing the longonjo project.   karen brings a unique skill set and a wealth of rare earth production and commercial experience to this stage of the company's development. she spent 21 years as managing director at neo materials chemicals & oxides for europe, part of the neoperformance materials (tsx:neo) that develops magnetic powders, rare earth magnets, magnetic assemblies, specialty chemicals, metals, and alloys for the rare earth sector.   karen oversaw new product development and held extended responsibility for international human capital strategy across factories in thailand, china and the usa. karen also has extensive experience in rare earth chemical engineering and oversaw the development of neo's separation facility at jiangyin, a cornerstone of the company's global operations. more recently, she has been consulting with pensana, particularly on downstream and market activities, providing her with strong familiarity with the company and its objectives.   tim george, ceo of pensana, commented:   "rocky's expertise has contributed hugely to navigating the various project development stages over the past five years and we are fortunate to retain his services going forward, while also giving him the well-deserved time to pursue family activities. i'm particularly pleased that karen, who has already been advising us for the past year, will seamlessly assume the broader role of coo."   karen brown added: "i am honoured to join pensana as coo during such a pivotal stage of the longonjo project development. drawing on my longstanding experience in rare earths and international operations, including working with multicultural teams across asia, europe and the usa, i look forward to collaborating with the talented pensana team to deliver operational excellence, expand market presence, and drive sustainable growth in this critical sector."   the information contained within this announcement is considered by the company to constitute inside information as stipulated under the market abuse regulations (eu) no.596/2014. upon the publication of this announcement via a regulatory information service, this inside information will be considered to be in the public domain. the person responsible for arranging for the release of this announcement on behalf of the company is paul atherley (chairman). - ends-   for further information, please contact: shareholder/analyst enquiries: pensana plc paul atherley, chairman ir@pensana.co.uk tim george, chief executive officer rob kaplan, chief financial officer  return to news summary

Label: Gesunken
09 sep 25   angle plc - change of adviser angle plc | agl | 5.8 0 0.0% | mkt cap: 18.6m    rns number : 4938y angle plc 09 september 2025   for immediate release 9 september 2025   angle plc ("the company")   appointment of nominated adviser and sole broker   angle plc (aim:agl otcqx:anpcy), a world-leading liquid biopsy company with innovative circulating tumour cell (ctc) solutions for use in research, drug development and clinical oncology, is pleased to announce that it has appointed cavendish capital markets limited as the company's nominated adviser and sole broker with immediate effect.       for further information:   angle plc +44 (0) 1483 343434 andrew newland, chief executive ian griffiths, finance director       cavendish (nomad and broker) geoff nash / isaac hooper (corporate finance) sunila de silva (corporate broking) nigel birks (life science specialist sales)   +44 (0) 20 7220 0500   fti consulting simon conway, ciara martin, sam purewal matthew ventimiglia (us)     +44 (0) 203 727 1000 +1 (212) 850 5624     for frequently used terms, please see the company's website on https://angleplc.com/investor-relations/glossary/     notes for editors   about angle plc   angle is a world-leading liquid biopsy company with innovative circulating tumour cell (ctc) solutions for use in research, drug development and clinical oncology using a simple blood sample. angle's fda cleared and patent protected circulating tumour cell (ctc) harvesting technology known as the parsortix® pc1 system enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.   angle's commercial businesses are focusing on diagnostic products and clinical services. diagnostic products include the parsortix® system, associated consumables and assays. the clinical services business is offered through angle's gclp-compliant laboratories.  services include custom made assay development and clinical trial testing for pharma.   over 115 peer-reviewed publications have demonstrated the performance of the parsortix system. for more information, visit www.angleplc.com     this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   appbcgdcxdgdgui return to news summary

Label: Gesunken
09 sep 25   norman broadbent plc - change of auditor norman broadbent plc | nbb | 238 6.0 2.6% | mkt cap: 4.54m    rns number : 4954y norman broadbent plc 09 september 2025   norman broadbent plc ("norman broadbent", or the "company")   change of auditor norman broadbent (lse aim: nbb), a leading executive search and interim management firm, announces that following the conclusion of a formal tender process led by the company's audit committee, the board has approved the appointment of cooper parry group limited ("cooper parry") as the company's new auditor. cooper parry will conduct the audit of the company's financial statements for the financial year ending 31 december 2025 and a proposal to reappoint them as auditor of the company will be subject to the approval of shareholders at the 2026 annual general meeting.   following the outcome of the formal tender process, kreston reeves llp ("kreston reeves"), the outgoing auditor, has resigned and has confirmed that there are no issues that need to be brought to the attention of the company's members or creditors under section 519 of the companies act 2006.   the board would like to thank kreston reeves for its professional service to the company throughout its tenure in office.   contacts:    norman broadbent plc  +44 (0)20 7484 0000 kevin davidson, ceo   mehr malik, cfo     cavendish capital markets limited +44 (0)20 7220 0500 nominated adviser and sole broker  julian blunt, seamus fricker, hamish waller - corporate finance  jasper berry, matt lewis - sales / corporate broking    gracechurch group +44 (0)20 4582 3500 financial media & investor relations normanbroadbent@gracechurchpr.com murdo montgomery  tommy bryson  anysia virdi     about norman broadbent:   norman broadbent (aim: nbb) is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the uk and internationally.    established as the first uk-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including consumer, financial services, industrials, life sciences, investor and tmt.   www.normanbroadbent.com   this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   appgzgglgrzgkzz return to news summary

Label: Neutral
10 sep 25   blackrock greater europe investment trust plc - total voting rights blackrock greater europe investment trust plc | brge | 572 0 0.0% | mkt cap: 543.9m    blackrock greater europe investment trust plc (the “company”) lei - 5493003r8fj6i76zuw55   voting rights and capital (article 15 transparency directive, dtr 5.6)   in conformity with the fca's disclosure guidance and transparency rules ("the rules") provision 5.6.1, the company would like to notify the market that as at 10 september 2025 its issued capital comprised 94,950,253 ordinary shares of £0.01 each, excluding 22,978,685 shares held in treasury.   shareholders should therefore use 94,950,253 (being the company’s issued share capital excluding shares held in treasury) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the company under the rules.     all enquiries:   caroline driscoll company secretary blackrock investment management (uk) limited tel: 0207 743 2427   10 september 2025  return to news summary

Label: Neutral
10 sep 25   greencore group plc - rule 2.9 announcement greencore group plc | gnc | 245 -0.50 (-0.2%) | mkt cap: 1,081m    rns number : 6445y greencore group plc 10 september 2025   not for release, publication or distribution in whole or in part, directly or indirectly in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of that jurisdiction for immediate release   10 september 2025 greencore group plc ("greencore") rule 2.9 announcement   in accordance with rule 2.9 of the city code on takeovers and mergers, greencore confirms that as at close of business on 9 september 2025 its issued share capital consisted of 442,532,851 ordinary shares of £0.01 each and 1 special rights preference share of €1.26. greencore does not hold any ordinary shares in treasury. the international securities identification number (the "isin") for greencore's ordinary shares is ie0003864109. greencore has a sponsored american depositary receipts ("adr") programme for which bank of new york mellon acts as the sponsored depositary bank. one adr represents four ordinary shares of greencore. the adrs trade on the us over-the-counter market under the symbol gncgy. the cusip number is 394181101 and the isin is us3941811016. this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   rttllmjtmtbmbpa return to news summary

Label: Gesunken
10 sep 25   warehouse reit plc - board changes warehouse reit plc | whr | 113 0 0.0% | mkt cap: 480.5m    rns number : 6693y warehouse reit plc 10 september 2025   not for release, publication or distribution in whole or in part in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of that jurisdiction     10 september 2025   warehouse reit plc ("warehouse reit" or the "company"))   board changes   following the announcement on 8 september 2025 by wapping bidco ltd ("bidco"), a newly-formed company indirectly owned by investment funds advised by affiliates of blackstone inc. ("blackstone"),  that its offer for warehouse reit has been declared wholly unconditional, the current directors of warehouse reit comprising neil kirton (chairman), aimee pitman, lynette lackey, dominic o'rourke, simon hope and stephen barrow have all resigned as directors of the company.  peter krause and sumedha goenka, representatives of blackstone, have been appointed as non-executive directors in their place.   peter krause is a senior managing director in the real estate group of blackstone based in london. mr. krause currently focuses on blackstone's investments in the logistics sector across europe. since joining blackstone in 2011, mr. krause has been involved in a number of blackstone's logistics investments in europe, including logicor, mileway, st. modwen properties plc, and hansteen holdings plc.   sumedha goenka is a managing director in the real estate group of blackstone and is also based in london. since joining blackstone in 2013, ms. goenka has been involved in various investments in europe including officefirst, hi partners and mileway.   there are no disclosures to be made in accordance with uklr 6.4.8 r of the uk listing rules in relation to the appointment of mr. krause and ms. goenka.   enquiries:   warehouse reit plc     via fti consulting   fti consulting (financial pr & ir adviser) dido laurimore richard gotla     +44 (0) 203 727 1000 g10 capital limited (part of the iqeq) (aifm ) maria baldwin   +44 (0) 20 7397 5450     this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   boaukonrvvukrar return to news summary

Label: Neutral
10 sep 25   blackrock throgmorton trust plc - total voting rights blackrock throgmorton trust plc gbp | thrg | 580 0 0.0% | mkt cap: 441.6m    blackrock throgmorton trust plc (the “company”) lei - 5493003b7ets1jedpf59   voting rights and capital (article 15 transparency directive, dtr 5.6)   in conformity with the fca's disclosure guidance and transparency rules ("the rules") provision 5.6.1, the company would like to notify the market that as at 10 september 2025 its issued capital comprised 76,176,864 ordinary shares of £0.05 each, excluding 27,033,000 shares held in treasury.   shareholders should therefore use 76,176,864 (being the company’s issued share capital excluding shares held in treasury) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the company under the rules.     all enquiries:   kevin mayger company secretary blackrock investment management (uk) limited tel: 0207 743 1098   10 september 2025   release return to news summary

Label: Gesunken